WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bio-Affinity Technologies, Inc. …
Latest News
Andy McOrmond Joined CNBC’s ETF Edge
Andy McOrmond, Managing Director, joined Bob Pisani on CNBC’s ETF Edge to discuss his views on ETF trends this summer, and what traders will be up to in …
WallachBeth Announces Completion of ABVC BioPharma, Inc. (Nasdaq: ABVC) $4.22 Million Registered Direct Offering
WallachBeth announced the completion of the purchase and sale of 2,000,000 shares of common stock of ABVC BioPharma, Inc. (Nasdaq: ABVC), and warrants to …